Home
All Journals
Expert Opinion on Drug Safety
List of Issues
Volume 14, Issue 11

Expert Opinion on Drug Safety

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Expert Opinion on Drug Safety, Volume 14, Issue 11 (2015)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Drug Safety, Volume 14, Issue 11 (2015)

See all volumes and issues

Vol 23, 2024 Vol 22, 2023 Vol 21, 2022 Vol 20, 2021 Vol 19, 2020 Vol 18, 2019 Vol 17, 2018 Vol 16, 2017 Vol 15, 2016 Volume 14, 2015 Vol 13, 2014 Vol 12, 2013 Vol 11, 2012 Vol 10, 2011 Vol 9, 2010 Vol 8, 2009 Vol 7, 2008 Vol 6, 2007 Vol 5, 2006 Vol 4, 2005 Vol 3, 2004 Vol 2, 2003 Vol 1, 2002

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Editorial

The changing landscape of adverse drug events associated with chronic hepatitis C virus therapy

Michael A Smith (Assistant Professor of Clinical Pharmacy) PharmD BCPS, Bryan L Love (Associate Professor) PharmD BCPS & Rima A Mohammad (Clinical Assistant Professor, Clinical Pharmacy Specialist – General Surgery/Nutrition) PharmD BCPS

Pages: 1649-1652

Published online: 12 Sep 2015

AbstractforThe changing landscape of adverse drug events associated with chronic hepatitis C virus therapy | Full Text | References | PDF (227.7 KB)

856 Views
5 CrossRef citations
0Altmetric

Free Access

Original Research

Article

Fluoroquinolone-associated tendon-rupture: a summary of reports in the Food and Drug Administration’s adverse event reporting system

Rasha M Arabyat, Dennis W Raisch PhD, June M McKoy & Charles L Bennett

Pages: 1653-1660

Published online: 22 Sep 2015

AbstractforFluoroquinolone-associated tendon-rupture: a summary of reports in the Food and Drug Administration’s adverse event reporting system | Full Text | References | PDF (426.6 KB)

1111 Views
46 CrossRef citations
0Altmetric

Article

Trastuzumab-induced cardiotoxicity in elderly women with HER-2-positive breast cancer: a meta-analysis of real-world data

Henry WC Leung (Director of Radiation Oncology) MD MPH & Agnes LF Chan (Director of Pharmacy, Assistant professor) PhD MAMM BSc Pharm

Pages: 1661-1671

Published online: 13 Oct 2015

AbstractforTrastuzumab-induced cardiotoxicity in elderly women with HER-2-positive breast cancer: a meta-analysis of real-world data | Full Text | References | PDF (897.2 KB) | Supplemental

483 Views
18 CrossRef citations
0Altmetric

Article

Safety profile of tasimelteon, a melatonin MT₁ and MT₂ receptor agonist: pooled safety analyses from six clinical studies

Damien Leger MD PhD, Maria-Antonia Quera-Salva MD PhD, Marie-Françoise Vecchierini MD PhD, Pascale Ogrizek MD, Christina A Perry MBA & Marlene A Dressman PhD

Pages: 1673-1685

Published online: 22 Sep 2015

AbstractforSafety profile of tasimelteon, a melatonin MT₁ and MT₂ receptor agonist: pooled safety analyses from six clinical studies | Full Text | References | PDF (500.5 KB)

303 Views
15 CrossRef citations
0Altmetric

Reviews

The safety of polymyxin antibiotics

Theodoros Kelesidis MD PhD & Matthew E Falagas MD MSc DSc

Pages: 1687-1701

Published online: 12 Sep 2015

AbstractforThe safety of polymyxin antibiotics | Full Text | References | PDF (513.4 KB) | Supplemental

1038 Views
75 CrossRef citations
0Altmetric

Safety and tolerability of anticonvulsant medication in bipolar disorder

Eva Maria Pichler MD, Georg Hattwich MD, Heinz Grunze MD & Moritz Muehlbacher MD

Pages: 1703-1724

Published online: 11 Sep 2015

AbstractforSafety and tolerability of anticonvulsant medication in bipolar disorder | Full Text | References | PDF (561.2 KB)

747 Views
8 CrossRef citations
0Altmetric

The safety of treatments for angioedema with hereditary C1 inhibitor deficiency

Andrea Zanichelli, Maddalena Alessandra Wu, Arnaldo Andreoli, Marta Mansi & Marco Cicardi

Pages: 1725-1736

Published online: 01 Oct 2015

AbstractforThe safety of treatments for angioedema with hereditary C1 inhibitor deficiency | Full Text | References | PDF (383.8 KB)

481 Views
7 CrossRef citations
0Altmetric

Risk of progressive multifocal leukoencephalopathy in patients with multiple sclerosis

Michele Faulkner PharmD

Pages: 1737-1748

Published online: 22 Sep 2015

AbstractforRisk of progressive multifocal leukoencephalopathy in patients with multiple sclerosis | Full Text | References | PDF (426.1 KB)

1466 Views
33 CrossRef citations
0Altmetric

Hydroxyurea therapy for sickle cell anemia

Patrick T McGann MD MS & Russell E Ware MD PhD

Pages: 1749-1758

Published online: 14 Sep 2015

AbstractforHydroxyurea therapy for sickle cell anemia | Full Text | References | PDF (683 KB)

2134 Views
136 CrossRef citations
0Altmetric

The safety of anticholinergic bronchodilators for the treatment of chronic obstructive pulmonary disease

DP Tashkin

Pages: 1759-1772

Published online: 24 Sep 2015

AbstractforThe safety of anticholinergic bronchodilators for the treatment of chronic obstructive pulmonary disease | Full Text | References | PDF (415.9 KB)

759 Views
12 CrossRef citations
0Altmetric

Comparative safety evaluation of selective androgen receptor modulators and anabolic androgenic steroids

Seul Min Choi (Senior Research Scientist) & Byung-Mu Lee (Professor)

Pages: 1773-1785

Published online: 24 Sep 2015

AbstractforComparative safety evaluation of selective androgen receptor modulators and anabolic androgenic steroids | Full Text | References | PDF (1.3 MB)

968 Views
29 CrossRef citations
0Altmetric

Drug Evaluation

Article

The safety of daclatasvir for the treatment of hepatitis C

Syed-Mohammed Jafri & Stuart C. Gordon

Pages: 1787-1797

Published online: 16 Nov 2015

AbstractforThe safety of daclatasvir for the treatment of hepatitis C | Full Text | References | PDF (251.3 KB)

187 Views
2 CrossRef citations
0Altmetric

Erratum

Correction

Erratum

Pages: 1799-1800

Published online: 16 Nov 2015

CitationforErratum | Full Text | PDF (127.2 KB)

446 Views
0 CrossRef citations
0Altmetric

Free Access

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Glass bead-activated clotting time (gb-ACT) for monitoring the anticoagulation effects in elderly patients with high risk of venous thromboembolism (VTE)

Pingan Peng et al.

Article | Published online: 20 May 2024

Post-marketing safety concerns with abrocitinib: a real-world pharmacovigilance analysis of the FDA adverse event reporting system

Zhou Zhu et al.

Article | Published online: 17 May 2024

Hematological toxicity of cyclin-dependent kinase 4/6 inhibitors in patients with breast cancer: a network meta-analysis and pharmacovigilance study

Haiying Ding et al.

Review Article | Published online: 16 May 2024

Adverse tumor events induced by Ranitidine: an analysis based on the FAERS Database

Tian Liu et al.

Article | Published online: 16 May 2024

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Drug Safety (Vol.14, Iss.11, 2015)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?